The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity (Q112284807)
Jump to navigation
Jump to search
scientific article published on 16 December 2021
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity |
scientific article published on 16 December 2021 |
Statements
The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin α6β4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity (English)
Ana Tadijan
Jonathan D Humphries
Ivana Samaržija
Nikolina Stojanović
Junzhe Zha
Kristina Čuljak
Marija Tomić
Mladen Paradžik
Davor Nestić
Heemin Kang
Martin J Humphries
Andreja Ambriović-Ristov
16 December 2021
16 December 2021
1 reference